How to Buy Nektar Therapeutics Stock
Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical firm dedicated to the global discovery and advancement of therapies addressing significant unmet medical requirements.
Nektar Therapeutics stock last closed at $60.98, up 0.1% from the previous day, and has increased 608.25% in one year. It has overperformed other stocks in the Biotechnology industry by 6.8 percentage points. Nektar Therapeutics stock is currently +630.3% from its 52-week low of $8.35, and -44.06% from its 52-week high of $109.00.
There are currently 33.79M NKTR shares outstanding. The market capitalization of NKTR is $2.06B. In the past 24 hours, 910,000 NKTR shares were traded.
How to Buy Nektar Therapeutics Stock
Not sure how to invest in Nektar Therapeutics stock? Here's how.
- Decide where to buy Nektar Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you choose where to buy Nektar Therapeutics stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Pick your method of payment and add your info.
- Evaluate Nektar Therapeutics stock: The Nektar Therapeutics ticker symbol is NKTR. Is Nektar Therapeutics stock a good investment? Should you buy shares of NKTR? How do NKTR's underlying business fundamentals look? Do top analysts think Nektar Therapeutics is a good buy? Why has NKTR's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if NKTR is a good stock to buy).
- Execute your NKTR buy order: Decide if you will purchase NKTR shares at the current market price or use a limit order to buy NKTR shares at a specific price.
- Get notifications regarding your NKTR investment: Create a watchlist to track your new investment in Nektar Therapeutics shares.
Step 1: Decide where to buy Nektar Therapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy NKTR stock.
Our preferred brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the right brokerage, you need to fill out some personal info so you can buy NKTR today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to create your new trading account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have opened your account on the best beginner stock app, you need to deposit funds:
Watch the video below for more details depositing money into your new brokerage account.
Step 4: Evaluate Nektar Therapeutics stock
Once you have decided on the best place to buy Nektar Therapeutics stock, it's important to evaluate their stock before you invest, so you can wrap your head around the risk as well as the upside.
Nektar Therapeutics quick stats
Nektar Therapeutics Due Diligence Checks
WallStreetZen was built to help average investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on NKTR's stock page.
Is NKTR stock properly valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge NKTR's true value.
Using relative valuations measures:
- NKTR may be undervalued based on its P/B ratio of 3.58x, relative to Biotechnology industry P/B ratio of 4.95x
You can do additional valuation analysis on NKTR's stock here.
NKTR Financial Summary
Positive Health Checks:
- There are more short-term assets than long-term liabilities on the NKTR balance sheet.
- Total NKTR debt is lower than 5 years ago, relative to shareholder equity.
- NKTR has cash burn of 204640000. It has sufficient cash and short-term investments to cover this for at least one year.
- NKTR has a low debt to equity ratio of 0.33.
- There are more short-term assets than short-term liabilities on the NKTR balance sheet.
- NKTR has $568.60M in cash and short term investments. This is enough to cover its annual cash burn of $204.64M.
Negative Health Checks:
- NKTR profit margin has gone down from -152.5% to -284.2% in the past year.
Do Wall Street analysts think it's a good time to buy NKTR stock
Out of 6 Equities analysts who monitor NKTR, the consensus analyst rating on Nektar Therapeutics is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent NKTR Analyst Recommendations
Mayank Mamtani, a top 4% analyst from B. Riley Securities reiterates NKTR with a strong buy rating and raises their NKTR price target from $105.00 to $150.00, on Feb 23, 2026.
B. Riley Securities's Mayank Mamtani raised their price target on Nektar Therapeutics (NASDAQ: NKTR) by 42.9% from $105 to $150 on 2026/02/23. The analyst reiterated their Strong Buy rating on the stock.
Mamtani contextualized their price target hike by referring to Nektar Therapeutics' recently reported 52-week maintenance data for REZOLVE-AD, and the removal of the equity financing overhang.
Those factors establish "a compelling catalyst roadmap," the analyst argued, detailing that "the longer-term efficacy and durability of Rezpeg in alopecia areata and Atopic Dermatitis, along with infrequent dosing, could drive (1) peak risk-adjusted sales to $2B, (2) improve Nektar Therapeutics' competitive position against JAK inhibitors and biologics, and (3) potentially accelerate Phase 3 AtD enrollment."
You can dive deeper into what analysts are projecting on the Nektar Therapeutics stock forecast page.
NKTR Momentum
NKTR Performance Metrics
Last year, NKTR revenue was $55.63M. During the past five year, NKTR's revenue has grown by -15.08% per year. This was slower than the Biotechnology industry average of 32.37%.
Find out more about NKTR's earnings and revenue performance here.
What are NKTR insiders up to?
In the last year, insiders at NKTR have sold more shares than they have bought.
Howard W. Robin, President CEO of NKTR, was the latest NKTR insider to sell. They sold $334,455.00 worth of NKTR stock on Jun 17, 2026.
Dig into more about who owns NKTR shares here.
Does NKTR stock generate passive income?
No, Nektar Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about NKTR
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your NKTR buy order
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually the best for newer investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.
Click the Open Trade button and your broker will execute the order.
If you want more help with investing in stocks on eToro, click the helpful video below:
Step 6: Get notifications regarding your NKTR investment
Now that you own some NKTR shares, you'll want to keep up with your investment.
Put NKTR on a watchlist to get the latest updates about your NKTR stock.
NKTR Feed
How to Buy Stock in Nektar Therapeutics
To reiterate, here are the 6 steps to buy stock in Nektar Therapeutics:
- Decide where to buy Nektar Therapeutics stock
- Open your brokerage account
- Deposit money your investment account
- Evaluate Nektar Therapeutics stock
- Execute your NKTR buy order
- Get notifications regarding your NKTR investment
If you require a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to track your investment in Nektar Therapeutics, create your watchlist below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.